K(+) channels regulate diaphragm resting membrane potential and action potential duration, and hence force. Certain blockers of these channels, e.g. tetraethylammonium (TEA), increase twitch force of normal diaphragm. To further address whether these agents may be useful in the treatment of diaphragm weakness, studies examined the effects of TEA on force of overtly diseased muscle. Diaphragm from two mouse models of muscular dystrophy (mdx and dy/dy) was studied in vitro. Diaphragm from both models was significantly weaker than diaphragm from control animals. TEA (10 mM) increased twitch force of both mdx diaphragm (P<0.005) and dy/dy diaphragm (P<0.0005), as well as force of diaphragm from non-diseased animals. The percent force increase of mdx diaphragm was at least as great as that of non-diseased muscle (15.3 vs 9.2%, P=0.14), and the percent force increase of dy/dy diaphragm was significantly greater than that of non-diseased muscle (22.7 vs 10.2%, P<0.02). Absolute force increases normalized for cross-sectional area were comparable for healthy and diseased diaphragm, however. These findings indicate that TEA increases force of both dystrophin-deficient and merosin-deficient dystrophic mouse diaphragm muscle.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0034-5687(00)00218-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Malformed mdx myofibers have normal cytoskeletal architecture yet altered EC coupling and stress-induced Ca2+ signaling.
Am J Physiol Cell Physiol
September 2009
Univ. of Maryland School of Medicine, Dept. of Physiology, 685 W. Baltimore St., HSF-1, Rm, 580, Baltimore, MD 21201, USA.
Skeletal muscle function is dependent on its highly regular structure. In studies of dystrophic (dy/dy) mice, the proportion of malformed myofibers decreases after prolonged whole muscle stimulation, suggesting that the malformed myofibers are more prone to injury. The aim of this study was to assess morphology and to measure excitation-contraction (EC) coupling (Ca(2+) transients) and susceptibility to osmotic stress (Ca(2+) sparks) of enzymatically isolated muscle fibers of the extensor digitorum longus (EDL) and flexor digitorum brevis (FDB) muscles from young (2-3 mo) and old (8-9 mo) mdx and age-matched control mice (C57BL10).
View Article and Find Full Text PDFAnimal models for genetic neuromuscular diseases.
J Mol Neurosci
March 2008
Dept of Genetics and Evolutionary Biology, University of Sao Paulo, Sao Paulo, Brasil.
The neuromuscular disorders are a heterogeneous group of genetic diseases, caused by mutations in genes coding sarcolemmal, sarcomeric, and citosolic muscle proteins. Deficiencies or loss of function of these proteins leads to variable degree of progressive loss of motor ability. Several animal models, manifesting phenotypes observed in neuromuscular diseases, have been identified in nature or generated in laboratory.
View Article and Find Full Text PDFMerosin (laminin-2) localization in basal lamina of normal skeletal muscle fibers and changes in plasma membrane of merosin-deficient skeletal muscle fibers.
Med Electron Microsc
December 2003
Department of Neurology, Showa University Fujigaoka Hospital, Aoba-Ku, Yokohama 227-8517, Japan.
Primary deficiency of merosin causes a severe congenital muscular dystrophy (CMD) and a mouse dystrophy (dy/dy mouse). Also, its secondary deficiency is seen in some CMD with abnormal glycosylation of Alpha-dystroglycan, an extracellular membrane protein, which is the receptor of merosin and binds to dystrophin underlying the sarcolenma via Beta-dystroglycan, a transmembrane protein. In immunogold and freeze-etch electron microscopic studies, merosin in basal lamina of normal skeletal muscles has a zonation in the distribution and is localized at the lamina lucida of muscle basal lamina, and dystrophin molecules are often closed to merosin molecules at the inside and outside surface of muscle plasma membrane.
View Article and Find Full Text PDFThree mouse models of muscular dystrophy: the natural history of strength and fatigue in dystrophin-, dystrophin/utrophin-, and laminin alpha2-deficient mice.
Neuromuscul Disord
November 2001
Department of Neurology, Washington University School of Medicine, Box 8111 660 S. Euclid, Saint Louis, MO 63110, USA.
To optimize and evaluate treatments for muscular dystrophy, it is important to know the natural history of the disease in the absence of therapeutic intervention. Here we characterized disease progression of three mutant mouse strains of muscular dystrophy: mdx mice, which lack dystrophin; mdx:utrn-/- mice, which also lack utrophin; and dy/dy mice, which are deficient in laminin alpha2. Normal mice show a marked increase in forelimb strength over the first 10 weeks of life and little fatigue (<5%) over five consecutive strength trials.
View Article and Find Full Text PDFElectrotransfer of naked DNA in the skeletal muscles of animal models of muscular dystrophies.
Gene Ther
July 2001
INSERM U 523, Hôpital de la Salpêtrière, Paris, France.
The electrotransfer of naked DNA has recently been adapted to the transduction of skeletal muscle fibers. We investigated the short- and long-term efficacy of this methodology in wild-type animals and in mouse models of congenital muscular dystrophy (dy/dy, dy(2J)/dy(2J)), or Duchenne muscular dystrophy (mdx/mdx). Using a reporter construct, the short-term efficacy of fiber transduction reached 40% and was similar in wild-type, dy/dy and dy(2J)/dy(2J) animals, indicating that ongoing muscle fibrosis was not a major obstacle to the electrotransfer-mediated gene transfer.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!